InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+20.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Tetrault Lynn A., 董事. Director active across 3 companies, notably Neogenomics INC. In total, 16 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €141k. Activity tracked since 2 June 2021. The latest transaction was filed on 1 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Tetrault Lynn A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
3,553 股Common StockSEC:0001645512-26-000003:0
4,000 股Common StockSEC:0001104659-25-061704:0
12,254 股0Common StockSEC:0001077183-25-000127:0
7,000 股@ US$8.139225.3% 占其流量Common StockSEC:0001077183-25-000100:0
标准退出：2025年8月7日 (T+90)
3,199 股@ US$18.9933.1% 占其流量Common StockSEC:0001104659-24-098944:0
4,300 股@ US$18.9944.0% 占其流量Common StockSEC:0001104659-24-094012:0
10,000 股@ US$4.1522.8% 占其流量Common StockSEC:0001104659-24-089634:0
11,336 股0Common StockSEC:0001077183-24-000135:0
3,000 股Common StockSEC:0001104659-24-074768:0
6,112 股@ US$15.965144.8% 占其流量Common StockSEC:0001077183-24-000034:0
1,507 股@ US$11.608.1% 占其流量Common StockSEC:0001077183-23-000064:0
15,556 股0Common StockSEC:0001077183-22-000107:0
3,334 股@ US$7.270.0022% mcap52.7% 占其流量Common StockSEC:0001077183-22-000087:0
838 股0Common StockSEC:0001077183-21-000227:0
1,389 股@ US$9.115.5% 占其流量Common StockSEC:0001077183-21-000168:0
3,081 股0Common StockSEC:0001077183-21-000158:0
16 条申报中的 16 条
About Tetrault Lynn A.
TETRAULT LYNN A. is Administrateur at Neogenomics INC, Rhythm Pharmaceuticals, INC. and ALUMIS INC. She has 16 filings in total, and across the recent sample of 16 filings, buys total EUR 50760 and sells total EUR 89995 between 2021-06-04 and 2026-07-02. The most common transaction type is Levée d'options.
